MarketIQ Analyst Report for MediaAlpha Inc.

700 SOUTH FLOWER STREET, SUITE 640, LOS ANGELES, CA, US
MAX

Last Updated: 14 Nov 2024

Executive Summary

MediaAlpha Inc. (MAX) is a publicly traded company in the insurance industry. The company has a market capitalization of $828.7 million and trades on the NYSE. MAX's latest stock price is $12.63. The company's fundamentals are weak, with negative earnings per share and a low profit margin. However, MAX's technical analysis is more positive, with the stock price above its 50-day and 200-day moving averages. Analysts have a mixed view of MAX, with five strong buy ratings, two buy ratings, one hold rating, and no sell ratings. The average analyst target price is $24.29.

Company Overview

MediaAlpha Inc. operates an insurance customer acquisition platform in the United States. The company's platform connects insurance carriers with potential customers through online marketing channels. MAX's customers include some of the largest insurance carriers in the United States.

Fundamental Analysis

MAX's financial performance has been weak in recent quarters. The company reported a net loss of $32.2 million in the latest quarter, and its earnings per share were -$0.322. MAX's profit margin is also low, at just 1.41%. The company's revenue growth has been strong, however, with revenue increasing by 2.475% year-over-year in the latest quarter.

Technical Analysis

MAX's technical analysis is more positive than its fundamental analysis. The stock price is above its 50-day and 200-day moving averages, and the relative strength index (RSI) is above 50. This indicates that the stock is in a bullish trend.

Short Term Outlook

The short-term outlook for MAX is mixed. The company's fundamentals are weak, but its technical analysis is more positive. The stock price is likely to continue to trade in a range between $12 and $14 in the near term.

Long Term Outlook

The long-term outlook for MAX is more positive. The company's revenue growth is strong, and it is well-positioned to benefit from the growing demand for insurance. MAX's stock price is likely to rise over the long term.

Analyst Recommendations

Analysts have a mixed view of MAX. Five analysts have a strong buy rating on the stock, two analysts have a buy rating, one analyst has a hold rating, and no analysts have a sell rating. The average analyst target price is $24.29.